Lymphoma is the most common cancer in cats. Understanding treatment options and their welfare implications helps owners make decisions that prioritise their cat's quality of life.
Feline lymphoma treatment decisions require careful welfare assessment balancing potential benefit against treatment burden. Small cell lymphoma treatment with oral medication is minimally invasive and most cats maintain excellent quality of life while responding, making treatment clearly welfare-positive when working. High-grade lymphoma chemotherapy decisions are more complex: the potential for remission must be weighed against the stress of frequent clinic visits and the side effects of aggressive chemotherapy in older cats. Owners often require guidance about the difference between treating for cure and treating for quality of life. Palliative care that maintains comfort without aggressive treatment is a legitimate and welfare-respecting choice when intensive treatment is not appropriate for the individual cat.